— Jeff Ward, Lehigh Valley News Briefs
Thermo Fisher Scientific’s first-quarter results topped estimates slightly, but the shares fell after the numbers came out Wednesday.
The company warned of the effects of tariffs on China, which increase costs for Thermo Fisher. Thermo is also concerned about cuts in government funding for medical studies, which will affect customers in academia.
The maker of scientific and medical equipment reported adjusted earnings per share of $5.15 and revenue of $10.36 billion, both just above Wall Street forecasts. The shares fell all the same on Wednesday, down $3.09 to $431.64. The stock has been a dud for quite awhile.
Thermo Fisher is based in Massachusetts but has operations in the Lehigh Valley.
In the first-quarter report, Thermo estimated adjusted earnings per share for 2025 of $21.76 to $22.84, down from $23.10 to $23.50. The midpoint of the new lower range is $1 below the old one.
The revenue forecast for the year is $43.3 billion to $44.2 billion.
Shares of Thermo Fisher traded at $435.00 in early trading Thursday. The 52-week high for the company is $627.88, almost $200 above today’s early price.
–Disclosure: I own shares in Thermo Fisher.
Lehigh Valley News Briefs 